Galileo Life Sciences, Inc. (MDRM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Revenue | - | - | - | 1656.00 | 7850.00 |
| Cost of Revenue | - | - | - | 938.00 | 5158.00 |
| Gross Profit | - | - | - | 718.00 | 2692.00 |
| Operating Expenses | 270.72 Thousand | 55.21 Thousand | 363.61 Thousand | 158.99 Thousand | 11.46 Thousand |
| Selling, General and Administrative Expenses | 270.72 Thousand | 55.21 Thousand | 363.61 Thousand | 137.62 Thousand | 7400.00 |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 270.72 Thousand | 55.21 Thousand | 363.61 Thousand | 159.93 Thousand | 16.62 Thousand |
| Operating Income | -271.37 Thousand | -55.21 Thousand | -363.61 Thousand | -158.27 Thousand | -8777.00 |
| Interest Expense | 649.00 | - | - | - | - |
| Income Tax Expense | - | - | - | - | - |
| Earnings before Tax | -248.24 Thousand | -52.6 Thousand | -363.61 Thousand | -158.27 Thousand | -8777.00 |
| Net Income | -248.24 Thousand | -52.6 Thousand | -363.61 Thousand | -158.27 Thousand | -8777.00 |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 123.35 Million | 195.48 Million | 195.48 Million | 146.11 Million | 22.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.35 Million | 195.48 Million | 195.48 Million | 146.11 Million | 22.65 Million |
| Gross Margin | - | - | - | 0.43 | 0.34 |
| EBIT Margin | - | - | - | -95.58 | -1.12 |
| Profit Margin | - | - | - | -95.58 | -1.12 |
| EBITDA | -270.72 Thousand | -270.72 Thousand | -55.21 Thousand | -363.61 Thousand | -158.27 Thousand |
| Earnings Before Tax Margin | - | - | - | -95.58 | -1.12 |
| Breakdown | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 FY | 2014 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 112.53 Thousand | 816.55 Thousand | 200.37 Thousand | 204.25 Thousand | 270.72 Thousand | 26.02 Thousand |
| Selling, General and Administrative Expenses | 112.53 Thousand | 816.55 Thousand | 200.37 Thousand | 204.25 Thousand | - | 26.02 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 112.53 Thousand | 816.55 Thousand | 200.37 Thousand | 204.25 Thousand | 270.72 Thousand | 26.02 Thousand |
| Operating Income | -200.6 Thousand | -934.85 Thousand | -294.52 Thousand | -204.75 Thousand | -271.37 Thousand | -26.08 Thousand |
| Interest Expense | 1351.00 | 2887.00 | 1039.00 | - | 649.00 | - |
| Income Tax Expense | -86.71 Thousand | -115.05 Thousand | -93.11 Thousand | - | - | - |
| Earnings before Tax | -188.19 Thousand | -932.38 Thousand | -289.3 Thousand | -184.92 Thousand | -248.24 Thousand | -23.45 Thousand |
| Net Income | -188.19 Thousand | -932.38 Thousand | -289.3 Thousand | -184.92 Thousand | -248.24 Thousand | -23.45 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.00 | - | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.00 | - | - | -0.00 |
| Weighted Average Shares Outstanding | 110.71 Million | 92.78 Million | 81.58 Million | - | 123.35 Million | 75.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 110.71 Million | 92.78 Million | 81.58 Million | - | 123.35 Million | 75.48 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -112.53 Thousand | -816.9 Thousand | -200.37 Thousand | -200.95 Thousand | - | -28.65 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
BRAINP
AHGIF
REXR-PC
AIMIRT
UNIR
CCLDP